Browsing Tag
Serum Institute of India
8 posts
ImmunityBio targets U.S. BCG shortage with exclusive Tokyo-172 agreement and FDA pathway plan
BCG supply is still a U.S. bladder cancer bottleneck. ImmunityBio’s Tokyo deal could widen access, if regulators move with it.
Is NB.1.8.1 already in India? Inside the ICMR’s variant surveillance in May 2025
NB.1.8.1 variant not yet detected in India, says ICMR; airports and labs intensify COVID surveillance as Hong Kong battles a deadly surge.
Wockhardt UK and Serum Life Sciences UK join forces to deliver 150 million vaccine doses annually from new fill-finish facility
Find out how Wockhardt and Serum Life Sciences UK are reshaping global vaccine supply with a new high-capacity facility—read more now.
Biocon to sell 15% stake in Biocon Biologics to Serum Institute of India
Biocon has agreed to divest a stake of around 15% in its subsidiary — Biocon Biologics Limited (BBL)…
Magma Fincorp shareholders approve acquisition by Rising Sun Holdings
Magma Fincorp said that its shareholders have approved Rising Sun Holdings’ (RSHPL) acquisition of a controlling stake in…
Rising Sun Holdings to acquire controlling stake in Magma Fincorp
Rising Sun Holdings (RSHPL), a company controlled by Serum Institute of India CEO Adar Poonawalla, has agreed to…
India grants emergency approval to Covishield and Covaxin vaccines for Covid-19
In a significant development in the battle against Covid-19, the Drugs Controller General of India (DCGI) has granted…
India’s DCGI grants emergency approval to Covishield and Covaxin vaccines
In a major step forward in India’s fight against the Covid-19 pandemic, the Drugs Controller General of India…